El Pollo Loco Holdings,Inc. AnnouncesFirst Quarter 2024 Financial Results
COSTA MESA, Calif., May 02, 2024 -- El Pollo Loco Holdings, Inc. today announced financial results for the 13-week period ended March 27, 2024. Highlights for the first quarter ended March 27, 2024 compared to the first quarter ended March 29, 2023 were as follows Total revenue was 116.2 million compared to 114.5 million.System-wide comparable restaurant sales increased by 5.1.Income from operations was 9.7 million compared to 7.8 million.Restaurant contr
Read at finance.yahoo.com
Gish Biomedical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gish Biomedical stock to make a market-neutral strategy. Peer analysis of Gish Biomedical could also be used in its relative valuation, which is a method of valuing Gish Biomedical by comparing valuation metrics with similar companies.
Peers
Gish Biomedical Related Equities
ACLS | Axcelis Technologies | 14.23 | ||||
AVNT | Avient Corp | 2.32 | ||||
PH | Parker Hannifin | 2.10 | ||||
JELD | Jeld Wen | 1.00 | ||||
HNFSB | Hanover Foods | 0.00 | ||||
TBBB | BBB Foods | 0.70 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Gish Stock
If you are still planning to invest in Gish Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gish Biomedical's history and understand the potential risks before investing.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |